“In our practices right now, the biggest challenge we have is being acquired by hospital systems,” says R. Jonathan Henderson, MD.
In this video, LUGPA President R. Jonathan Henderson, MD, discusses the biggest challenges LUGPA member practices currently face. Henderson, a urologist with Regional Urology LLC in Shreveport, Louisiana, was speaking at the 2021 LUGPA annual meeting.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.